Companies › OVID

OVID THERAPEUTICS INC (OVID)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001636651 · EDGAR filings · Updated 2026-07-08

OVID THERAPEUTICS INC (OVID) has reported institutional ownership of 79.7%, with 103 institutional managers holding positions valued at $233.2M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-08 — Insider transaction reported (Form 4)
• 2026-07-08 — Initial insider ownership filed (Form 3)
• 2026-07-08 — SCHEDULE 13G/A filed
• 2026-07-08 — Current report (8-K) filed
• 2026-06-17 — Insider transaction reported (Form 4)
• 2026-06-17 — Initial insider ownership filed (Form 3)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, OVID THERAPEUTICS INC has 103 institutional holders and institutional ownership of 79.7%.

Insider activity

Insiders reported 6 transactions (0 buys, 2 sells) across 4 reporting insiders, with a net reported value of −$29.3K.

Data flags from SEC filings

Related companies

LYELL IMMUNOPHARMA INC (LYEL) · RXSIGHT INC (RXST) · STRATA CRITICAL MEDICAL INC (SRTA) · Minerva Neurosciences Inc (NERV) · OPKO HEALTH INC (OPK) · VIEMED HEALTHCARE INC (VMD)